A Study of Capmatinib (INC280) in NSCLC Patients With MET Exon 14 Alterations Who Have Received Prior MET Inhibitor

Clinical trial NCT02750215 · COMPLETED

Trial details

NCT number: NCT02750215
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Non-small Cell Neoplasm of Lung Stage IV

Start date: 2016-05-01
Primary completion: 2021-05-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.